Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improved Diagnosis of Congenital Heart Disease by MRI using Vasovist (CHD Vasovist)
2006-007042-18Phase 4Completed
- Sponsor
- King's College London
- Start
- Jan 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gadofosveset in Cardiovascular Malformation (CVM) (2 arms), sponsored by King's College London. Primary endpoints: Image quality comparison between Vasovist and Magnevist, Signal-to-noise ratio (SNR) comparison and 1 more. Started Jan 2009; status: completed.
02
Drugs
gadofosveset
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2006-007042-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007042-18.